Gallbladder Cancer Epidemiology Forecast 2025-2034

Gallbladder cancer is a rare but aggressive disease. In the United States, an estimated 12,610 new cases will be diagnosed in 2025 (6,040 in men, 6,570 in women), with 4,400 deaths expected (1,950 in men, and 2,450 in women). In 2024, the National Cancer Institute (NCI) estimated 12,350 cases of gallbladder and bile duct cancer combined, with 4,530 deaths.

Gallbladder Cancer Epidemiology Forecast Report Coverage

The “Gallbladder Cancer Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of gallbladder cancer. It projects the future incidence and prevalence rates of gallbladder cancer across various populations. The study covers age, gender, and type as major determinants of the gallbladder cancer-affected population. The report highlights patterns in the prevalence of gallbladder cancer over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of gallbladder cancer in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Gallbladder Cancer Disease Overview

Gallbladder cancer is a rare but aggressive malignancy that develops in the gallbladder. It often remains asymptomatic in early stages, leading to late diagnosis and poor prognosis. Symptoms may include abdominal pain, jaundice, nausea, and weight loss. Risk factors include gallstones, chronic inflammation, obesity, and a family history of the disease. Treatment options depend on the stage and may involve surgery, chemotherapy, or radiation. Early detection improves outcomes, but most cases are diagnosed at advanced stages, making effective treatment challenging.

Gallbladder Cancer: Treatment Overview

Gallbladder cancer treatment depends on the stage and overall health of the patient. Surgery is the primary option for early-stage cancer, involving cholecystectomy (gallbladder removal) or radical resection for wider spread. Chemotherapy (e.g., gemcitabine, cisplatin) and radiation therapy are used for advanced or inoperable cases. Targeted therapy and immunotherapy may be considered for specific genetic mutations. Palliative care helps manage symptoms in late-stage disease. Early detection improves outcomes, but gallbladder cancer is often diagnosed at an advanced stage, making treatment challenging.

Epidemiology

The gallbladder cancer epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for gallbladder cancer by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for gallbladder cancer and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to the National Cancer Institute (NCI), 12,350 cases of gallbladder and bile duct cancer were diagnosed in 2024, with an estimated 4,530 deaths.
• In 2025, in the United Kingdom, approximately 4,400 deaths are expected to occur due to gallbladder cancer and surrounding large bile ducts (1,950 in men, 2,450 in women).
• Around 40% of 12,610 new gallbladder related diseases, are expected to be gallbladder cancer.
• Only 20% (1 out of 5 cases) of gallbladder cancers are detected in early stages before spreading.

Country-wise Gallbladder Cancer Epidemiology

The gallbladder cancer epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

In the United States, gallbladder and bile duct cancers are relatively rare. In 2025, an estimated 12,610 new gallbladder cancer cases are projected to be diagnosed in the United States (6,040 in men, 6,570 in women). These statistics highlight the ongoing burden of these cancers, despite their lower incidence compared to other malignancies. Estimated by the Cancer Research UK, approximately 820 deaths of gallbladder cancer every year are anticipated to occur during 2038-2040.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of gallbladder cancer based on several factors.
• Gallbladder Cancer Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of gallbladder cancer are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of gallbladder cancer epidemiology in the 8 major markets?
• What will be the total number of patients with gallbladder cancer across the 8 major markets during the forecast period?
• What was the country-wise prevalence of gallbladder cancer in the 8 major markets in the historical period?
• Which country will have the highest number of gallbladder cancer patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of gallbladder cancer during the forecast period of 2025-2034?
• What are the currently available treatments for gallbladder cancer?
• What are the disease risks, signs, symptoms, and unmet needs of gallbladder cancer?

This product will be delivered within 3-5 business days.